Jul. 31 at 1:43 AM
$IXHL I can tell one thing for sure. This SP doesn't belongs under a buck. Shit on it all you want. But these results are blockbuster. The way they are moving the SP really reminds of
$TVGN last fall. It ran over
$3.0 before setting down and now it trades around 1.20- 1.60. Next year and the following are going to be huge for it. This ticker doesn't belongs under
$1. It got shorted at the tune of 6M shares Shorting biotech after FDA trial results is bread and butter. But when there's a strong catalyst such as this. I wouldn't count on it staying this low or going lower for too long. The price action here was manufactured to shake out retail for a little bit while they get their ducks in a row to run it up. Don't believe me, look the history of other tickers at the heels of trial results Past is prologue my friends.
